Life value

STELLAPHARM was born to care and protect patient’s health, to help enhancing their lives and living longer. Your health, for today and for future.

PANORAMA AND TRENDS OF THE GLOBAL PHARMACEUTICAL MARKET

With the development of the global economy, the growth of the total population and the aging of society, the demand for drugs is increasing, and the market size of the global pharmaceutical industry will maintain growth. stable.In 2023, the total global pharmaceutical market is estimated to be approximately US$1,6 trillion. This is an increase of

GOVERNMENT OF VIETNAM AGREES ON DEVELOPMENT OF LAW ON AMENDMENTS TO LAW ON PHARMACY

According to the Resolution, the Government of Vietnam highly appreciates the Ministry of Health of Vietnam for taking charge and cooperating with ministries and central authorities in actively preparing and presenting Bills according to the Law on Promulgation of Legislative Documents 2015; and Agrees on the necessity of the development of the Law on amendments

AMENDED LAW ON PHARMACY 2016 EXPECTED TO GIVE BETTER ACCESS TO MEDICATION

Despite answering a number of state management requirements, the Pharmacy Law 2016 still displays certain inadequacies. Its amendments are supposed to provide patients with better access to new medication. To address inadequacies in the Law on Pharmacy 2016, the Government has already submitted a draft Law on Amendments for the Pharmacy Law 2016 to the

PROMOTING VIETNAMESE PHARMACEUTICAL INDUSTRY

Vietnamese pharmaceutical market grew from $2.7 billion in 2015 to $7 billion in 2022 and is forecast to reach more than $10 billion by 2026. The Vietnamese pharmaceutical industry is seeing great advantages.People’s spending on health was increasingly high giving pharmaceutical enterprises great potential for development, said Associate Professor, PhD. Lê Văn Truyền, former Deputy

EUROPEAN COMMISSION LAUNCHES THE CRITICAL MEDICINES ALLIANCE TO HELP PREVENT AND ADDRESS SHORTAGES OF CRITICAL MEDICINE

The European Commission’s Health Emergency Preparedness and Response Authority (HERA), working with the Belgian Presidency of the Council of the EU, have today launched the Critical Medicines Alliance at the margins of the informal EPSCO Council meeting of health ministers, as part of the actions to build a strong European Health Union. The Alliance brings

HO CHI MINH CITY TO HAVE COUNTRY'S FIRST LARGEST PHARMACEUTICAL INDUSTRIAL PARK

Under the People’s Committee of Ho Chi Minh City-approved project, the southern metropolis will have the country’s first largest medical and pharmaceutical industrial park. The city Department of Health today said that the municipal People’s Committee has just issued the Decision No. 657/QD-UBND to approve the Project ‘Developing Ho Chi Minh City’s pharmaceutical industry to

STELLAPHARM WAS LISTED TOP 10 FASTEST GROWING ENTERPRISES IN VIETNAM IN 2024

The top 10 businesses consist of Binh Thuan Plastic Group JSC, HD Securities Corporation, Orient Securities Corporation, Imedia Technology and Services JSC, SOL E&C Construction Investment JSC, Vietnam Vitadairy Milk JSC, Taseco Land Investment JSC, Stellapharm J.V. Co. Ltd., CNC Technology Solutions JSC, and Bee Logistics Corporation. The top 10 in the 2024 list of

AMENDED PHARMACY LAW MUST SUPPORT FOREIGN ENTERPRISES IN VIETNAM

The amended Law on Pharmacy is key in ensuring comprehensive and adequate healthcare resources for the people. HÀ NỘI — Deputy Prime Minister Trần Hồng Hà emphasised that the amended Law on Pharmacy must include regulations to support foreign pharmaceutical enterprises to invest in drug production and technology transfer in Vietnam. Speaking at a meeting

PHARMACEUTICAL INDUSTRY MUST BE MANAGED UNDER MARKET RULES: DEPUTY PRIME MINISTER

Deputy Prime Minister Tran Hong Ha underlined the need to manage the pharmaceutical industry under market rules, ensuring publicity, transparency, quality control, safety, and cheapest prices during a meeting in Hanoi. Deputy Prime Minister Tran Hong Ha underlined the need to manage the pharmaceutical industry under market rules, ensuring publicity, transparency, quality control, safety, and

POPULAR DRUGS MUST BE BID CENTRALLY

Drugs that are commonly used and have large volumes must be subject to centralized national or local bidding and selection of qualified manufacturers, Deputy Prime Minister Tran Hong Ha requested. Chairing a meeting on the draft decree guiding the 2023 Bidding Law on contractor selection, Deputy Prime Minister Tran Hong Ha said that in addition

WHY IS IT DIFFICULT FOR PATIENTS TO ACCESS NEW DRUGS?

Only 42 new drugs out of 460 types circulated globally are available in Vietnam, due to long licensing procedures and time, affecting patients. On January 21, a representative of the Ministry of Health said that generic drug prices in Vietnam are low compared to countries in the ASEAN region (for most main treatment groups). While

HIGH GROWTH POTENTIAL IN PHARMACEUTICAL INDUSTRY

It is critical for pharmaceutical companies to improve competitiveness with a focus on research and development (R&D), production technology and digitalisation. According to experts, this will help them expand their shares in the domestic market which remains dominated by imported drugs and extend their international reach. Vietnam’s pharmaceutical market has significant potential. The Health Ministry

PROPOSING NEW REGULATIONS ON CLINICAL DRUG TRIALS

The Ministry of Health is drafting a Circular amending and supplementing a number of articles of Circular 29/2018/TT-BYT dated October 29, 10 of the Minister of Health regulating clinical drug trials. According to the provisions of Circular 29, regarding the legality of clinical drug trial records: The registration application and the content of the registration

INNOVATIVE MEDICINE SALES TOP THE LIST FOR MULTINATIONALS

Multinational corporations are giving priority to bringing more innovative medicines to Vietnam to tap into growing local demand. Pfizer plans to bring numerous innovative medicines to Vietnam over the next four years. This is in line with its global strategy, as the company has made significant progress towards launching 19 new products over an 18-month

THE GAME-CHANGERS IN PHARMACEUTICALS

Innovative pharmaceuticals are emerging as a game-changer reshaping the industry, which is urging Vietnamese authorities to have supporting policies to tap into new potential. At Pfizer, new innovative vaccines are being studied to keep abreast of new viruses and bacteria that threaten human lives and livelihoods. They include a two-in-one flu and coronavirus jab, and

VIETNAM’S PHARMACEUTICAL INDUSTRY SETS DEVELOPMENT TARGETS FOR THE NEXT DECADE

By 2030, Vietnam will become a center for manufacturing or processing of, and transfer of technologies for, brand-name medicines in the ASEAN region. Under Prime Minister Decision 1165/QD-TTg, approving the National Strategy for development of the domestic pharmaceutical industry through 2030, with a vision toward 2045, it is expected that the domestic pharmaceutical industry’s production

INCENTIVES PROPOSED FOR DEVELOPMENT OF PHARMACEUTICAL INDUSTRY

The Ministry of Health has released a draft Law Amending the 2016 Law on Pharmacy, providing many attractive incentives for boosting the development of the pharmaceutical industry. The Ministry of Health (MOH) has released a draft Law Amending the 2016 Law on Pharmacy, providing many attractive incentives for boosting the development of the pharmaceutical industry.The

MEDICINE PRICES IN VIETNAM IN LOWER RANGE IN ASIA-PACIFIC: CONFERENCE

Medicine prices in Vietnam are in the lower range compared to those in other countries in the region, heard the Asian Federation for Pharmaceutical Sciences (AFPS) Conference 2023 that is taking place in Hanoi from November 8-10, 2023. Vice Health Minister Nguyen Thi Lien Huong speaks at the event (Photo: VNA) Themed “Collaboration for Breakthroughs

IT IS TIME FOR FOREIGN-INVESTED PHARMACEUTICAL COMPANIES TO EXPANDED

With a large population and a growing demand for pharmaceuticals, Vietnam currently ranks among the top 17 countries with the highest pharmaceutical industry growth rates globally. According to the Pharmaceutical Industry Development Program, by 2025, domestically produced drugs are expected to account for 75% of consumption and 60% of market value. Additionally, it is projected

FORUM DISCUSSES NEW APPROACHES FOR PHARMA-HEALTHCARE DEVELOPMENT IN VIETNAM

New approaches for pharma-healthcare development in Vietnam were the main topic of discussion at a forum in Hanoi on July 20, 2023. At the event, held by the Dau tu (Investment Review) Newspaper, participants heard that the investment trend in the medicine and pharmacy fields changed a lot in the direction of focusing on innovation,

POLICY BREAKTHROUGH NEEDED TO BETTER ATTRACT INVESTMENT TO PHARMA SECTOR: EXPERT

The lack of a breakthrough in vision and infeasible legal policies, worsened by complicated administrative procedures in pharmacy sector, are among limitations that make Vietnam less attractive to foreign investors. The lack of a breakthrough in vision and infeasible legal policies, worsened by complicated administrative procedures in pharmacy sector, are among limitations that make Vietnam

VIETNAM AIMING TO BECOME REGIONAL PHARMACEUTICAL PRODUCTION CENTER

Vietnam has set a target of becoming a high-value pharmaceutical production center in the region under its strategy for the development of the pharmaceutical sector by 2030 with a vision to 2045. Under the strategy, which was approved by Deputy Prime Minister Tran Hong Ha on October 9, Vietnam will strive to develop its pharmaceutical

VIETNAM MUST CLEARLY DETERMINE PHARMACEUTICAL SECTOR’S GOALS FOR THE FUTURE

The pharmaceutical sector plays an important role in healthcare, meaning development goals must be established. Deputy Prime Minister Trần Hồng Hà made the statement on Wednesday afternoon after hearing a report on the draft National Strategy for the development of Việt Nam’s pharmaceutical sector by 2030. Hà said the draft strategy not only sets out

VIETNAM REALISES PHARMACEUTICAL INDUSTRY DEVELOPMENT STRATEGY

Vietnam is striving to develop the pharmaceutical industry to level 4, the highest as classified by the World Health Organisation, according to the National Strategy for Pharmaceutical Industry Development by 2023, with a vision toward 2045. Vietnam is striving to develop the pharmaceutical industry to level 4, the highest as classified by the World Health

EU PUBLISHES PROPOSED DRUG LAWS OVERHAUL, SETTING UP TUSSLE WITH INDUSTRY

LONDON, April 26, 2023 (Reuters) – Brussels on Wednesday published a long-awaited draft of its proposed overhaul of laws governing the European Union’s pharmaceuticals industry, setting up a tussle with drugmakers which warn they will invest and innovate elsewhere. The biggest overhaul of existing medical laws in two decades is aimed at ensuring all Europeans

INNOVATE TO ELEVATE VIETNAM'S HEALTHCARE INDUSTRY

The “Healthcare Innovation Forum”, a platform that brings together local and international experts to discuss and share experiences on innovative solutions in building a sustainable healthcare system worldwide and to drive the adoption of innovative approaches and technologies to transform healthcare in Vietnam. Diseases never stop developing, nor does innovation to deal with these obstacles.

HO CHI MINH CITY PLANS TO BUILD 300 - HECTARE PHARMACEUTICAL INDUSTRIAL PARK

The Ho Chi Minh City Department of Health is seeking feedback on the plan to construct a 300-hectare pharmaceutical industrial park during the 2025-30 period, a step to prepare for the city’s export of medical products in the future. People work inside a medical laboratory in Ho Chi Minh City – Photo: DUYEN PHAN / Tuoi

SHORTEN LICENSING PROCEDURES, ENCOURAGE INVESTMENT, AND TRANSFER PHARMACEUTICAL TECHNOLOGY

The Circular is an important legal basis for attracting investment activities and transferring technology for drug production, especially original brand name drugs, patented drugs, specialized drugs, special treatments, and prescription drugs. generic drugs in the form of high-tech dosage forms, vaccines, reference biological products, and similar biological products according to the orientations in the “Program

PHARMACEUTICAL INDUSTRY STRIVES TO PRODUCE NEW DRUG FORMS

Vietnam is focusing on improving research capacity and application of new drug production technology, promoting clinical pharmacy development and strengthening supervision of safe and reasonable drug use. Vietnam is focusing on improving research capacity and application of new drug production technology, promoting clinical pharmacy development and strengthening supervision of safe and reasonable drug use, aiming

TOP 10 REPUTABLE PHARMACEUTICAL COMPANIES IN 2023

On November 28, 2023, Vietnam Evaluation Report Joint Stock Company (Vietnam Report) officially announced the Top 10 prestigious Pharmaceutical Companies in 2023. Top 10 reputable Pharmaceutical Companies are built on scientific and objective principles. Companies are evaluated and ranked based on 3 main criteria: (1) Financial capacity shown on the most recent year’s financial statements;

DRUG ADMINISTRATION GRANTS LICENCES FOR FIRST THREE MADE-IN-VIỆT NAM MOLNUPIRAVIR PRODUCTS

HÀ NỘI — The Drug Administration of Việt Nam under the Ministry of Health has issued the list of three COVID-19 treatment drugs produced in Việt Nam that contain the antiviral ingredient Molnupiravir, which have been granted certificates of registration for conditional use. The three products – Molravir 400mg produced by Boston Việt Nam Pharma (based in

VIETNAM’S PHARMACEUTICAL INDUSTRY DEVELOPMENT STRATEGY

Vietnam has set its sights on becoming a high-value pharmaceutical production hub within the region.Deputy Prime Minister Trần Hồng Hà recently backed a decision that has been hailed a significant milestone in Vietnam’s pharmaceutical sector. Signed on October 9, Decision No. 1165/QĐ-TTg has approved the National Strategy for developing Vietnam’s pharmaceutical industry until 2030, with

315 DRUGS ARE PROPOSED TO APPLY PRICE NEGOTIATION

The Ministry of Health is drafting a Circular promulgating a list of drugs, testing supplies, and medical equipment eligible for price negotiation and stipulating the process and procedures for selecting contractors for applicable bidding packages. form of price negotiation. According to the draft, the construction of the drug list is applied in the form of

PHARMACEUTICAL COMPANIES URGED TO INVEST IN R&D, IMPROVE COMPETITIVENESS

It is critical for pharmaceutical companies to improve competitiveness with a focus on research and development (R&D), production technology and digitalisation. According to experts, this will help them expand their shares in the domestic market which remains being dominated by imported drugs and extend their international reach.Vietnam’s pharmaceutical market has significant potential. The Ministry of

A FOCUS ON THE IMPROVEMENT OF PEOPLE’S LIVES BY PROVIDING EFFECTIVE AND AFFORDABLE TREATMENTS.

By Mr. Ong Van Dung, General Director, Stellapharm Stellapharm (former name was STADA-VN – a Joint Venture Pharmaceutical Company formed in 2002 with a Vietnamesecompany named M.S.T and German cooperation named STADA Arzneimittel). Stellapharm has become one of the leading generic pharmaceutical manufacturers in Vietnam, we follow the global quality standard in accordance with European

THROUGH THE MPP ORGANIZATION, STELLAPHARM GETS THE 3rd APPROVAL TO PRODUCE SHIONOGI'S COVID-19 ORAL PILL

As one of seven generic drug manufacturers selected by MPP and becoming a sub-licensee of Shionogi – a Japanese pharmaceutical manufacturer to produce of XOCOVA™ drug, generic version. Stellapharm is honored and proud to have contributed to repelling the COVID-19 pandemic with drugs. This is the third oral product in the world to be recognized

BIG PHARMA BETS ON AI TO SPEED UP CLINICAL TRIALS

Major drugmakers are using artificial intelligence to find patients for clinical trials quickly, or to reduce the number of people needed to test medicines, both accelerating drug development and potentially saving millions of dollars.Human studies are the most expensive and time-consuming part of drug development as it can take years to recruit patients and trial

OVERVIEW OF VIETNAM’S PHARMACEUTICAL MANUFACTURING INDUSTRY 2023. WHAT DIRECTION FOR PHARMACEUTICAL ENTERPRISES?

Despite having a good market, the pharmaceutical manufacturing in Vietnam still faces many difficulties. This difficulty comes from industry competition, world competition and technological development. In order for the pharmaceutical manufacturing to develop, what should pharmaceutical enterprises do? Overview of Vietnam’s pharmaceutical manufacturing industry 2023.The market for the pharmaceutical industry in Vietnam is relatively active:The

LAUNCHING HEPATITIS C PRODUCT "LESOVIR" IN VIETNAM

Lesovir is manufactured by its EU-GMP facility and distributed via exclusive distributor, Khuong Duy Pharma Co., Ltd. The product is a fixed-combination preparation of Ledipasvir 90 mg and Sofosbuvir 400 mg) is an oral drug used for the treatment of patients with chronic hepatitis C virus (HCV) genotype 1, 4, 5, or 6 infection which are common types in Asia including Vietnam.

THROUGH THE MPP ORGANIZATION, STELLAPHARM GETS THE APPROVAL TO PRODUCE PFIZER’S ANTI-COVID-19 PILL

On February 21, 2022, Stellapharm officially signed a contract with MPP (Medicines Patent Pool), a UNITED NATIONS-backed public health organization to become the only manufacturer in Vietnam allowed to produce a generic version of Pfizer’s oral COVID-19 treatment, nirmatrelvir, which will be co-packaged with ritonavir, under the voluntary licensing agreement between Pfizer and the MPP.

27 GENERIC MANUFACTURERS SIGN AGREEMENTS WITH MPP TO PRODUCE LOW-COST VERSIONS OF COVID-19 ANTIVIRAL MEDICATION MOLNUPIRAVIR FOR SUPPLY IN 105 LOW- AND-MIDDLE-INCOME COUNTRIES

20 January 2022 Geneva – The Medicines Patent Pool (MPP) announced today that it has signed agreements with 27 generic manufacturing companies for the manufacturing of the oral COVID-19 antiviral medication molnupiravir and supply in 105 low- and-middle-income countries (LMICs). The sublicence agreements are the result of the voluntary licensing agreement signed by MPP and

STELLAPHARM SUPPORTS EUROPEAN PARTNERS IN COVID-19 PANDEMIC

Since the beginning of February this year, many consignments of Stella's pharmaceutical products with a total of nearly 200 million units have been urgently exported by air to markets in Germany, France, Austria, Belgium, Ireland, etc.

THROUGH THE MPP ORGANIZATION, STELLAPHARM GETS THE APPROVAL FROM MSD TO PRODUCE MOLNUPIRAVIR IN VIETNAM

On January 10, 2022, Stellapharm officially signed an agreement with MPP (Medicines Patent Pool), a UNITED NATIONS-backed public health organization to become the only manufacturer in Vietnam allowed to produce the COVID-19 treatment molnupiravir under the "Voluntary Licensing" program for MSD, a trade name of Merck & Co., Inc., Kenilworth, NJ, USA.

AN ORAL PILL FOR COVID-19? MOLNUPIRAVIR SHOWS PROMISE

[Updated to July 2021] The results of the trial demonstrate the safety, tolerability, and antiviral efficacy of molnupiravir to reduce replication of SARS-CoV-2 and accelerate clearance of infectious virus and support ongoing trials of molnupiravir to prevent progression of COVID-19 and eliminate onward transmission of SARS-CoV-2. After more than one year into the coronavirus disease

GROUNDBREAKING CEREMONY FOR HORMONE - STEROID - OINTMENT FACTORY COMPLYING WITH EU-GMP AND PIC/S

This will be the first steroid-hormone pharmaceutical factory in Vietnam and among a few ASEAN factories built in compliance with European Standards for this line of products.

COMPANY NAME CHANGE

Due to our strategic development of the Company, we are pleased to announce the change of Company Name: STADA - VN JOINT VENTURE CO., LTD. officially changed its name to STELLAPHARM J.V. CO., LTD. since 16 August 2019. Address, Tax code, Telephone/Fax Number remains unchanged.

EU-GMP INSPECTION, 2019

“Accrediting the fifth EU-GMP is one of our commitment on maintaining highest EU standards and quality of products with affordable prices” said by Choo Yan Ho, the Chairman.

EU-GMP INSPECTION, 2016

On 15 March 2016, the fourth EU-GMP Inspection was conducted at STADA – VN J.V. Co., Ltd., Binh Duong Branch, currently known as STELLAPHARM J.V. Co., Ltd. – Branch 1

JAPAN GMP ACCREDITATION, 2015

On 06 January 2015, STADA – VN J.V. Co., Ltd., Binh Duong Branch (the “STELLA” or “Factory II“), was appreciated by Ministry of Health, Labour and Welfare (the "MHLW") issued the certificate of Japan GMP for the product of Soleton 80 with its composition and strength: Zaltoprofen 80 mg

EU-GMP INSPECTION, 2013

On 19 March 2013, the third EU-GMP Inspection was conducted in five continuous days at STADA – VN J.V. Co., Ltd., Binh Duong Branch (the “Company” or “Factory II“), located at Vietnam – Singapore Industrial Park, Binh Duong and the Factory II was recognized as a pharma facility complying with European Good Manufacturing Practice issued

We produce a wide
range of prescription
and non-prescription drugs

Tefostad T300

Tefostad T300 (Tenofovir disoproxil fumarate) is used in conjunction with other antiretroviral agents (should not be used alone) in the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults, post-exposure prophylaxis of HIV infection and in treatment of chronic hepatitis B in adults.

Metformin STELLA 850 mg

Metformin STELLA 850 mg is indicated in treatment of type 2 diabetes mellitus, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control.

Felodipine STELLA 5 mg retard

Felodipine is used for management of hypertension and prophylaxis of stable angina pectoris. It has anti-anginal and anti-ischemic effects due to improved myocardial oxygen supply/demand balance.

Nifedipin T20 retard

Nifedipin T20 retard is used in treatment of the prophylaxis of angina, if especially element vasospastic as Prinzmetal's angina and treatment of hypertension.

Stadovas 5 CAP

Stadovas 5 CAP (Amlodipine) is used to treat hypertension, angina. The drug may be used as monotherapy or in combination with other antianginal medicinal products.

Bisostad 5

Bisostad 5 (Bisoprolol fumarate) is used to treat hypertension and angina pectoris. It is also used as an adjunct to standard therapy in patients with stable chronic heart failure.

Bisoprolol STELLA 10 mg

Bisoprolol is given as the fumarate in the management of hypertension and angina pectoris. The drug is also used as an adjunct in standard therapy in patients with stable chronic heart failure.

Xelostad 10

Xelostad 10 (Rivaroxaban) is used for prevention of venous thromboembolism (VTE) in adult patients, treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT and PE in adults.

Vytostad 10/20

Simvastatin and ezetimibe combination along with a proper diet to help lower "bad" cholesterol and fats (such as LDL-C, triglycerides) and increase "good" cholesterol (HDL-C) in the blood to help reduces the risk of heart disease, an intervention in individuals at significantly increased risk for atherosclerotic vascular disease due to hypercholesterolemia.

Irbeplus HCT 150/12.5

Irbeplus HCT is a combination of an angiotensin-II receptor antagonist (Irbesartan) and a thiazide diuretic (Hydrochlorothiazide). This combination has an additive antihypertensive effect, reducing blood pressure to a greater degree than either component alone.

Amioxilto 200

Amiodarone is an antiarrhythmic drug used to treat and prevent certain types of arrhythmias. These arrhythmias include ventricular tachycardia, ventricular fibrillation, and wide QRS tachycardia, as well as atrial fibrillation and paroxysmal supraventricular tachycardia. However, evidence in cardiac arrest is limited.

Castella 90

Castella 90 (Ticagrelor) is co-administered with acetylsalicylic in the prevention of atherothrombotic events in adult patients with acute coronary syndromes and with history of myocardial infarction and a high risk of developing an atherothrombotic event.

Statripsine

Statripsine (Alphachymotrypsine) is used for treatment of post traumatic, post-operative oedema, burn. The drug is orally or sublingually administered.

Zynadex 40

Zynadex 40 is used to treat various types of inflammation and edema, to reduce swelling caused by bruising, fractures, traumatic brain injury, postoperation, post-traumatic soft tissue swelling, and acute thrombophlebitis.

Sezstad 10

Sezstad 10 (Ezetimibe ) is indicated as adjunctive therapy to diet for primary hypercholesterolaemia, homozygous familial hypercholesterolaemia, homozygous familial sitosterolaemia.

Ezecept 20/10

Ezecept 20/10 containing ezetimibe and atorvastatin, is a lipid-lowering agent that selectively inhibits the intestinal absorption of cholesterol and related phytosterols and inhibits endogenous cholesterol synthesis.

Azoltel 400

Azoltel 400 contains albendazole, a benzimidazole carbamate derivative which is structurally related to hiabendazole and mebendazole. It has a wide spectrum of activity against intestinal nematodes.

Helix STELLA

Helix STELLA containing dried ivy leaf extract (Hedera helix L.) is used for adults and children above 1 in dry cough, productive cough, cough due to weather change, sore throat, bronchitis. This product is health supplement, not approved therapeutics claims.

Bicimax

Bicimax is used for supplementation of deficiencies of the vitamins B complex, vitamin C, calcium and magnesium: e.g., prolonged stress, prolonged infection and fever, intestinal diseases, gastrectomy, alcohol abuse, ...

Calcium STELLA 500 mg

Calcium STELLA 500 mg effervescent tablets with active ingredient calcium are used in the prevention and treatment of calcium deficiency, preventing osteoporosis, rickets... for adults and children.

Pravitce

Pravitce contains calcium and vitamin C. Its main use is to supplement these two substances for people suffering from nutritional deficiencies, during pregnancy, lactation, adolescents during growth, and the elderly.

Elnitine

Elnitine is used for supplementation of calcium and magnesium in for patients in convalescence, stress, elderly patients, menopausal women, children in growth.

Racetril 30

Racecadotril granules for oral suspension is prescribed for complementary symptomatic treatment of acute diarrhoea in infants (older than 3 months) and in children together with oral rehydration.

Gliptinestad 50

Gliptinestad (Sitagliptin 50 mg) is indicated to improve glycaemic control in adult patients with type 2 diabetes mellitus.

Lexostad 50

Sertraline is an antidepressant (selective serotonin reuptake inhibitors - SSRIs). Lexostad 50 (Sertraline) is commonly used for major depressive episodes, panic disorder, obsessive compulsive disorder (OCD). It may also be used for other conditions as determined by your healthcare provider.

Sulpistad 200

Sulpistad 200 (Amisulpride) is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.

Parastad Kid

Paracetamol is an effective alternative to aspirin as an analgesic-antipyretic agent; however, it is not a useful agent to treat inflammatory conditions. Paracetamol lowers body temperature in patients with fever but rarely lowers normal body temperature.

Partamol-Cafein

Partamol-Cafein is fixed-combination of paracetamol and caffeine that is indicated for treatment of most painful and febrile conditions, for example, headache, including migraine, backache, toothache.....

Aldenstad plus

Aldenstad plus (Alendronic acid; Cholecalciferol) is commonly used for treatment of bone diseases. It is indicated for the treatment of postmenopausal osteoporosis in women at risk of vitamin D insufficiency. It reduces the risk of vertebral and hip fractures.

Stadloric 200

Stadloric 200 (Celecoxib) is an antiinflammatory and antirheumatic product, non-steroids, commonly indicated in treatment and relief the signs and symptoms of pain, osteoarthritis, dysmenorrhoea.

Eperistad

Eperistad (Eperisone hydrochloride) is effective in improving myotonic symptoms such as stiffness of shoulders, cervical pain, muscle contraction type headache, dizziness, lower back pain and rigidity of extremeties which may accompany encephalomyelopathies, cervical syndrome, periarthritis of the shoulder or lumbago.

Myopain 150

Myopain 150 (tolperisone hydrochloride) is used for treatment of post-stroke spasticity in adults. It works on the spinal cord and centers in the brain to relieve contraction or muscle stiffness without a decrease in strength.

Molnupiravir STELLA 400 mg

Molnupiravir is indicated for the treatment of mild to moderate COVID-19 disease in adults with a positive diagnostic test for SARS-CoV-2 and with at least one risk factor for severe disease progression.

Flustad 75

Flustad 75 (Oseltamivir) is an antiviral drug for systemic use indicated for treatment and prevention of influenza in adults and children (including full term neonates) following contact with an infected person influenza but not a substitute for influenza vaccination.

Lesovir

Lesovir is a fixed-dose combination of ledipasvir and sofosbuvir which are direct-acting antiviral agents against the hepatitis C virus.

Stadfovir 25

Stadfovir 25 (Tenofovir alafenamide fumarate) is indicated for the treatment of chronic hepatitis B in adults and adolescents (aged 12 years and older with body weight at least 35 kg).

Spirastad Plus

Spirastad Plus is a fixed-combination preparation of spiramycin and metronidazole, which is indicated for treatment and prevention of buccodental infection.

Flazacort 6

Deflazacort is in a class of medications called corticosteroids. Its anti­inflammatory and immunosuppressive effects are used in treating asthma, arthritis, immune suppression in transplantation.

Stadsone 16

Methylprednisolone is a synthesis glucocorticoid. The drug Stadsone 16 is mainly used as treatment for some diseases including causes due to hematology, allergies, inflammation, cancer and autoimmune.

Predstad 20

contains prednisolone as its active ingredient, indicated for the treatment and/or suppression of inflammatory and allergic disorders. The drug is in the form of water-dispersible tablet.

Prednisolone STELLA 5 mg

Prednisolone is a synthetic, anti-inflammatory glucocorticoid. At high doses, this medicine has a dampening effect on the immune response.

Pranstad 1

Pranstad 1 (Repaglinide) is used as monotherapy as an adjunct for the management of type 2 diabetes mellitus in adults whose hyperglycaemia can no longer be controlled satisfactorily by diet, weight reduction and exercise.

Mopristad 5

Mopristad 5 (Mosapride citrate) is indicated for the treatment of gastrointestinal symptoms (heartburn, nausea/vomiting) associated with functional dyspepsia (chronic gastritis).

Alumastad

Alumastad contains dried aluminum hydroxide gel and magnesium hydroxide which are antacids pain reliever and indigestion discomfort by neutralizing acid, reducing the excess acidity in the stomach.

Smetstad

Smetstad (Diosmectite) is used in treatment of painful symptoms of oesophagitis and gastroenteritis, supporting of electrolyte fluid therapy in chronic and acute diarrhoea, particularly in children.

Zecein 80

Zecein 80 (Drotaverine) belongs to the group of smooth muscle spasmolytic agent indicated for treatment of pain syndromes of various organs: gastrointestinal, biliary, urogenital and vascular systems.

Arastad 20

Arastad 20 (Leflunomide) is used for treatment of active rheumatoid arthritis in adults, active psoriatic arthritis. It is used for adult patients (18 years of age and older).

BK-1

Emergency contraceptive pill BK-1 (Levonorgestrel) is administered within 72 hours of unprotected intercourse, or failure of contraceptive method.

Aliquina

Dequalinium chloride is an antiinfectives and antiseptics excl. combinations with corticosteroids, indicated for the treatment of bacterial vaginosis.

Stadmazol 500

Stadmazol 500 vaginal tablet contains clotrimazole, an imidazole derivative with a broad spectrum of antimycotic activity.

Amxolstad 30

Amxolstad 30 (Ambroxol hydrochloride) has mucokinetic and expectorant properties in acute and chronic diseases of the respiratory tract accompanied by abnormal bronchial secretions.

Amxolstad 60 mg/10 ml

Amxolstad 60 mg/10 ml (Ambroxol hydrochloride) has mucokinetic and expectorant properties in acute and chronic diseases of the respiratory tract accompanied by abnormal bronchial secretions.

Bamstad

Bamstad (Bambuterol hydrochloride) is indicated for management of asthma, bronchospasm and/or reversible airways obstruction in adults.

Bilazin 20

Bilazin 20 (Bilastine) is indicated in symptomatic treatment of allergic rhino-conjunctivitis (seasonal or perennial) and urticaria. The drug does not cause drowsiness.

Stadeltine

Stadeltine (Levocetirizine) is effective in the relief of nasal and ocular symptoms of seasonal, perennial allergic rhinitis and chronic idiopathic urticaria, for adult and adolescent patients.

Stadexmin

Betamethasone combined with Dexchlorpheniramine maleate is indicated for adults and children over 6 years old in symptomatic treatment of seasonal and perennial allergic rhinitis, symptomatic treatment of acute hives.

Stadgentri

Stadgentri is a topical cream combining the anti-inflammatory, antipruritic actions of betamethasone with the antifungal activity of clotrimazole and the broad-spectrum antibiotic activity of gentamicin sulfate.

Flucistad

Flucistad topical cream (Fusidic acid) is used alone or in combination with systemic treatment in dermatitis caused by susceptible strains of bacteria. The drug has no effect on fungi.

Shaping Tomorrow

We are embracing technology and partnership to leverage that strengthen to advance research, develop and produce new generic drugs.